Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;42(1):75-81.
doi: 10.14639/0392-100X-N1699.

Chronic rhinosinusitis with nasal polyps: how to identify eligible patients for biologics in clinical practice

Matteo Gelardi  1 , Corso Bocciolini  2 , Mario Notargiacomo  3 , Irene Schiavetti  4 , Cristiano Lingua  5 , Pietro Pecoraro  6 , Lucia Iannuzzi  7 , Vitaliano Antonio Quaranta  8 , Rossana Giancaspro  1 , Gianluca Ronca  1 , Michele Cassano  1 , Giorgio Ciprandi  9 ; Italian Study Group on Nasal Polyps
Collaborators, Affiliations

Chronic rhinosinusitis with nasal polyps: how to identify eligible patients for biologics in clinical practice

Matteo Gelardi et al. Acta Otorhinolaryngol Ital. 2022 Feb.

Abstract
in English, Italian

Objective: This study compared three severity measures for chronic rhinosinusitis with nasal polyps (CRSwNP). The outcome was to identify patients who are eligible for biological therapy.

Methods: 330 adult patients with CRSwNP were examined. Nasal polyp score (NPS), sinonasal outcome test (SNOT-22) and clinical-cytological grading (CCG) were compared. Clinical history, past surgery and asthma control test were also considered.

Results: Only 45 (13.6%) patients had a contextual positivity to the three severity measures. The concordance among tests was slight/fair. Patients with severe disease (all tests positive) had more impaired parameters. The mixed cytotype (OR = 4.07), nasal obstruction (OR = 10.06), post-nasal drip (OR = 1.98), embarrassment (OR = 2.53) and difficulty falling asleep (OR = 1.92) were significantly associated with severe CRSwNP.

Conclusions: To identify candidates for biological therapy, the contextual use of NPS, SNOT-22 and CCG is preferable. In this way, global assessment of CRSwNP, including morphology, inflammation, comorbidity, symptoms and quality of life is possible.

Rinosinusite cronica con poliposi nasale: come individuare i candidati alla terapia biologica nella pratica clinica.

Obiettivo: Questo studio confrontava 3 differenti indici di gravità della rinosinusite cronica con poliposi nasale (RSCcPN). L’obbiettivo era individuare i pazienti eleggibili al trattamento con farmaci biologici.

Metodi: 330 pazienti adulti con RSCcPN erano arruolati. Tutti i pazienti venivano valutati mediante nasal polyp score (NPS), sinonasal outcome test (SNOT-22) e clinical-cytological grading (CCG). Inoltre erano considerati la storia clinica, i pregressi interventi chirurgici ed il controllo dell’asma.

Risultati: Solamente 45 (13,6%) pazienti avevano i 3 indici positivi. La concordanza tra i 3 indici era bassa/modesta. I pazienti con la malattia grave (contestuale positività a tutti i test) avevano peggiori parametri. Il citotipo misto (OR = 4,07), l’ostruzione nasale (OR = 10,06), il post-nasal drip (OR = 1,98), il disagio (OR = 2,53), e la difficoltà ad addormentarsi (OR = 1,92) erano significativamente associati con la malattia grave.

Conclusioni: È preferibile utilizzare contemporaneamente i 3 test per individuare i pazienti candidati alla terapia biologica. In questo modo si può avere un quadro generale della malattia, comprendente la morfologia dei polipi, lo stato di infiammazione, le comorbidità, i sintomi e la qualità della vita.

Keywords: CCG; SNOT-22; biological therapy; chronic rhinosinusitis with nasal polyps; nasal polyp score.

PubMed Disclaimer

References

    1. Fokkens WJ, Lund VJ, Hopkins C, et al. . European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 2020;59(Suppl. 29):1-464. https://doi.org/10.4193/Rhin20.600 10.4193/Rhin20.600 - DOI - PubMed
    1. Orlandi RR, Kingdom TT, Hwang PH, et al. . International consensus statement on allergy and rhinology: rhinosinusitis. Int Forum Allergy Rhinol 2016;6(Suppl. 1):S22-209. https://doi.org/10.1002/alr.21695 10.1002/alr.21695 - DOI - PubMed
    1. Ciprandi G, Gelardi M. Chronic rhinosinusitis with nasal polyposis: the role of personalized and integrated medicine. Monaldi Arch Chest Dis 2021;91. https://doi.org/10.4081/monaldi.2021.1769 10.4081/monaldi.2021.1769 - DOI - PubMed
    1. Bachert C, Zhang L, Gevaert P. Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis. J Allergy Clin Immunol 2015;136:1431-1440. https://doi.org/10.1016/j.jaci.2015.10.010 10.1016/j.jaci.2015.10.010 - DOI - PubMed
    1. DeConde AS, Mace JC, Levy JM, et al. . Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Laryngoscope 2017;127:550-555. https://doi.org/10.1002/lary.26391 10.1002/lary.26391 - DOI - PMC - PubMed

Substances